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Protein labeling and engineeringIn the past two decades, with the rapid development of chemical biology, tremendous small-molecule
based toolkits were created by organic chemists, and were widely used to study and manipulate proteins
in order to dissect their complicated biological functions. This review summarizes some recent
progresses of bioorthogonal reactions for site-speciﬁc protein labeling and engineering, and highlights
the powers of using these methods to study the biological functions of some proteins.
 2015 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
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As one of the most abundant biomolecules, proteins are
involved in most of the biological processes and perform a wide
array of important functions within living organisms. Therefore,
the study and manipulation of protein functions are not only of
signiﬁcant importance to fundamental scientiﬁc research, but alsocritical to the development of biomedical and biotechnological
applications. Traditional genetics, molecular biology, biochemistry,
cell biology, and allied methods have provided various tools to
investigate the functions of proteins, and have led to tremendous
achievements including visualization of a protein using ﬂuorescent
protein fusions and silence of a protein expression using RNA
interferences. However, not all the proteins and related biological
processes are within the easy reach of those conventional
approaches. Fortunately, recent rapid progress in the chemical
biology ﬁeld provides abundant new technologies for the study
Figure 1. Three approaches to achieve the site-speciﬁc protein labeling and engineering. Schematic illustrations of site-speciﬁc incorporation of unnatural amino acids
followed by bioorthogonal reactions including ligations (a) and deprotections (b). (c) Schematic illustration of the ligand-directed chemistry for site-speciﬁc protein labeling
and engineering. UAA, unnatural amino acid; AA, natural amino acid; Lg, ligand.
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the modiﬁcation of speciﬁc proteins with functional probes
provides a powerful technique for the investigation of target pro-
teins and their complex functions in detail. So far, there are a large
variety of strategies developed by organic chemists to achieve site-
speciﬁc labeling and engineering of target proteins with functional
small molecules.1 Due to space limitations, this digest only focuses
on two strategies used for the site-speciﬁc protein labeling and
engineering: (1) Bioorthogonal reactions with genetically encoded
unnatural amino acids bearing functional groups that can be
speciﬁcally ligated or deprotected (Fig. 1a and b); (2) Ligand-
directed bioorthogonal reactions for site-speciﬁc modiﬁcations of
target proteins (Fig. 1c).
The ﬁrst strategy combines bioorthogonal reactions with
genetically encoded unnatural amino acids bearing functional
groups, such as aldehydes, ketones, azides, and alkenes, to facilitate
the site-speciﬁc protein labeling and engineering (Fig. 1a and b).2
Genetic code expansion and reprogramming enable the site-speci-
ﬁc incorporations of diverse designed unnatural amino acids into
proteins.3 By evolving orthogonal ribosomes, developing mutually
orthogonal synthetase/tRNA pairs and manipulating genomes, the
efﬁciency of unnatural amino acids incorporations and the num-
bers of unnatural amino acids that can be site-speciﬁcally encoded
are constantly increasing. Notablely, the development and applica-
tion of the pyrrolysyl-transfer RNA (tRNA) synthetase/tRNA pair for
unnatural amino acids incorporation have moved genetic code
expansion from bacteria to eukaryotic cells and multicellular
organisms.4
Although genetic code expansion is a powerful tool, it also has
some limitations, for example, genetic modiﬁcation and subse-
quent overexpression of proteins may perturb the physiological
condition of cells. Thus, another strategy named ligand-directed
chemistry for site-speciﬁc protein labeling that modiﬁes selective
endogenous proteins under their physiological conditions, was
developed (Fig. 1c).5 In this approach, a synthetic molecule con-
taining three functional groups including a target protein binding
ligand, a reactive linker and a functional probe is constructed,
and ﬁrstly its ligand part speciﬁcally binds to its target protein,
then driving a bioorthogonal reaction between the reactive linker
group with an amino acid located at the vicinity of the ligand-
binding site of the target protein facilitated by the proximity effect,
ﬁnally end with the labeling of the target protein with the
functional probe. Therefore, this method can satisfy the require-
ments of target selectivity and site speciﬁcity.Since these two methods revolutionized our abilities to site-
speciﬁcally label and manipulate intact proteins, these two areas
are rapidly growing and many elegant applications have been
recently reported. In this review, we summarize some recent
developments in these two ﬁelds using bioorthogonal reactions
for site-speciﬁc protein labeling and engineering.
Bioorthogonal reactions with genetically encoded unnatural
amino acids for site-speciﬁc protein labeling and engineering
In general, the bioorthogonal reactions used for site-speciﬁc
protein labeling and engineering based on genetically encoded
unnatural amino acids can be mainly classiﬁed into two categories:
ligation reactions (Fig. 1a) and deprotection reactions (Fig. 1b).
Bioorthogonal ligation reactions
Ligation reactions through aldehydes and ketones
Genetically encoded aldehydes and ketones can speciﬁcally
react with hydrazides and alkoxyamines to produce stable hydra-
zone and oxime, respectively (Scheme 1a),6 and were successfully
applied for the site-speciﬁc in vitro or cell surface protein labeling.7
However the unfavorable acidic conditions and slow kinetics of
these reactions prevent their applications in most intracellular
settings.7a,8 To overcome these shortcomings, aniline was
identiﬁed and used as a nucleophilic catalyst for both speciﬁc
cell surface and intracellular protein labeling (Scheme 1b).9
Based on the classic Pictet–Spengler reaction between aldehydes
and tryptamine nucleophiles, recently Bertozzi and co-workers
reported the Pictet–Spengler ligation reaction (Scheme 1c).10 In
this reaction, aldehydes react with alkoxyamines to form inter-
mediate oxyiminium ions, which then undergo intramolecular C–
C bond formations with indole nucleophiles to form hydrolytically
stable oxacarboline products. In conjunction with techniques for
genetic incorporations of unnatural amino acids bearing aldehydes,
the Pictet–Spengler ligation provides a unique tool to generate
stable bioconjugates for biomedical applications.
Ligation reactions through azides
Genetically encoded azide groups were ﬁrstly developed for the
site-speciﬁc biomolecule labeling by the Bertozzi group through a
process known as Staudinger ligation, a modiﬁcation of the classic
Staudinger reduction of azides with triphenylphosphine.11 In this
process, the proteins bearing alkyl azides undergo ligation reac-
tions to form stable amide bonds with triarylphosphine derivatives
Scheme 1. Bioorthogonal reactions of genetically encoded ketones/aldehydes with hydrazines or alkoxyamines for site-speciﬁc protein labeling and engineering. (a) Acid-
catalyzed reaction of genetically encoded aldehydes/ketones with amino nucleophiles. (b) Aniline-catalyzed reaction of genetically encoded aldehydes/ketones with
hydrazines or alkoxyamines. (c) Pictet–Spengler ligation of genetically encoded aldehydes with tryptamine nucleophiles.
Scheme 2. Staudinger ligations of azides and triarylphosphines for site-speciﬁc protein labeling and engineering. (a) The Staudinger ligation between genetically encoded
azides and triarylphosphines. (b) The traceless Staudinger ligation.
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some phosphine reagents, in which the acyl group is attached via
a cleavable linker to the phosphine group, were developed, and a
variant of this reaction was reported, named as ‘‘traceless
Staudinger ligation’’, where the phosphine oxide moiety is absent
in the ﬁnal bioconjugate (Scheme 2b).12 These Staudinger ligations
have been successfully used to site-speciﬁcally label protein
in vitro and in many different cellular conditions.13 Limitations ofthe Staudinger ligations are their slow kinetics and the oxidation
sensitivities of phosphines, therefore the phosphine reagents have
to be used at relatively high concentrations.11b
Besides Staudinger ligation, azides can also take part in [3+2]
cycloadditions with alkynes to yield stable triazoles, but high
temperature and pressure are normally required to form the tria-
zole products in a reasonable yield.14 There are generally two
strategies to improve the reaction: catalyzing the reaction with
Scheme 3. Copper-catalyzed azide–alkyne cycloadditions (CuACC) for site-speciﬁc protein labeling and engineering together with ligands including BPS, TBTA, TEOTA,
THPTA, BTTAA, BTTES, BTTP, and BTTPS for the coordination of Cu(I).
Scheme 4. Strain-promoted azide–alkyne 1,3-dipolar cycloadditions (SPAAC) for site-speciﬁc protein labeling and engineering together with strained cycloalkyne derivatives
OCT, DIFO, DIFBO, DIBO, BARAC, and TMTH used in SPAAC.
Scheme 5. Photoclick chemistry of genetically encoded O-allyltyrosines with tetrazoles for site-speciﬁc protein labeling and engineering.
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is termed as the copper catalyzed azide–alkyne cycloaddition
(CuAAC), and the latter is named as the strain-promoted alkyne–
azide cycloaddition (SPAAC).CuAAC, taking advantage of the formation of a dinuclear copper
intermediate to activate both terminal alkynes and azides,17 is a
representative of click reaction (Scheme 3).18 Moreover, the
Cu(I)-catalyzed cycloaddition can be further accelerated by the
Y. Gong, L. Pan / Tetrahedron Letters 56 (2015) 2123–2132 2127use of speciﬁc ligands for Cu(I).19 These ligands, such as BPS
(Scheme 3) and natural amino acid histidine, coordinate Cu(I) to
form activated copper catalysts that can promote the azide–alkyne
cycloaddition at low concentrations of Cu(I). However, the main
limitation of CuAAC is the toxicity of Cu(I),20 which is caused by
Cu(I)-mediated generation of reactive oxygen species (ROS) from
O2.21 Recently, the use of water-soluble ligands including TBTA,
TEOTA, THPTA, BTTAA, BTTES, BTTP, and BTTPS can reduce the
apparent copper-associated cytotoxicity by serving as reductants
to protect cells from ROS (Scheme 3).22 By using these rate-
accelerating ligands, the CuAAC have been used to site-speciﬁcally
label proteins in living Escherichia. coli and mammalian cells.23
SPAAC is another approach to accelerate the azide–alkyne
cycloaddition (Scheme 4). Cyclooctyne derivatives have been used
to label proteins containing genetically encoded azides in living
systems.24 To improve the reaction, more reactive cyclooctyne
compounds including diﬂuorocyclooctyne (DIFO) derivatives,
diﬂuorobenzocyclooctyne (DIFBO), dibenzocyclooctynes (DIBO),
and biarylazacyclooctynone compounds (BARAC) (Scheme 4) were
developed and have been used to probe azide-containing proteins
within complex biological systems including mammalian cells,
Caenorhabditis elegans and zebraﬁsh embryos.25 Recently, thi-
acycloheptynes, such as TMTH (Scheme 4), have been developed
as a new type of reagents for SPAAC.26
Ligation reactions through terminal alkenes and tetrazoles
Photoinduced organic reactions are also explored to enable the
site-speciﬁc protein labeling processes in biological settings. Lin
and co-workers developed the UV-light induced 1,3-dipolar
cycloaddition reactions between tetrazole derivativess and term-
inal alkenes (Scheme 5), also named as photoclick chemistry.27
By incorporations of tetrazole and alkene groups into proteins in
the forms of unnatural amino acids, the photoclick chemistry has
been used to site-speciﬁcally label and engineer proteins in vitro,
and also to visualize proteins in living bacteria and mammalian
cells.27,28 There are several advantages of the photoclick chemistry:
ﬁrst and foremost, its inducibility by light makes it a powerful tool
for spatiotemporal initiation of labeling reactions in living sys-
tems; second, the reaction is ﬂuorogenic and only the resulting
pyrazoline product is ﬂuorescent, which is helpful for living cell
imaging studies;27a third, the fast reaction kinetics, presenting a
signiﬁcantly faster bioorthogonal reaction than the Staudinger
ligation and the SPAAC.28a,29 Development of new tetrazole
reagents, which are highly reactive and can be light-activated at
wavelengths that are harmless to living cells, will make this
reaction more attractive.Scheme 6. Inverse-electron-demand Diels–Alder reactions between tetrazines and gene
norbornenes (Nor), bicyclononynes (BCN), and trans-cyclooctenes (TCO or sTCO) for siteLigation reactions through strained alkenes/alkynes and
tetrazines
In 2008, Fox and co-worker ﬁrstly reported a protein
bioconjugation strategy based on the inverse-electron-demand
Diels–Alder reaction between a tetrazine compound and a strained
trans-cyclooctene.30 Later, various unnatural amino acids bearing
strained alkene or alkyne groups, such as norbornenes (Nor), cyclo-
propenes (Cyp), bicyclononynes (BCN), and trans-cyclooctenes
(TCO or sTCO), were synthesized and genetically incorporated into
proteins for site-speciﬁc protein labeling and engineering with
tetrazines in living bacteria and mammalian cells (Scheme 6).31
These reactions are very speciﬁc, extraordinarily fast, and many
of the red tetrazine ﬂuorophores, whose ﬂuorescences are initially
quenched by the tetrazine, become strongly ﬂuorescent upon
cycloadditions with strained alkenes or alkynes, making them par-
ticularly useful for the labeling of proteins with low cellular abun-
dances and for tracking fast protein-involved biological processes.
Ligation reactions through cross-metathesis
Another bioorthogonal reaction involving alkenes is oleﬁn
metathesis, one of the most powerful organic reactions for the
construction of new carbon–carbon bonds. In 2008, Davis and
co-workers reported the ﬁrst utility of cross-metathesis in site-
speciﬁcally labeling proteins containing an allyl sulﬁde group
in vitro (Scheme 7).32 They screened a small panel of alkenes and
identiﬁed S-allylcysteine as the most efﬁcient substrate for the
cross-metathesis reaction with allyl alcohol using the Hoveyda–
Grubbs second-generation catalyst.33 Recently, they further
developed a rapid and efﬁcient cross-metathesis reaction using
Se-allyl-selenocysteine for in vitro site-speciﬁc labeling and engi-
neering of proteins.34
Ligation reactions through palladium-catalyzed cross-coupling
Palladium-catalyzed cross-coupling reactions have also been
exploited to site-speciﬁcally label and engineer proteins. Initial
reports using palladium-mediated cross-coupling reactions on
proteins containing genetically encoded p-iodophenylalanine or
p-boronophenylalanine suffered from very low reaction conver-
sions or harsh reaction conditions.35 Later, Davis and co-workers
developed a water-soluble palladium catalyst, a sodium salt of 2-
amino-4,6-dihydroxypyrimidine in complex with palladium
[Pd(OAc)2(ADHP)2], for the Suzuki–Miyaura cross-coupling
reaction between a genetically encoded p-iodobenzyl group and
various aryl and alkenyl boronic acids (Scheme 8a).36 The
improved palladium-mediated Suzuki–Miyaura cross-coupling
reactions typically reached completion within 1 h at 37 C, andtically encoded strained alkenes or alkynes including cyclopropenes (Cyp), alkynes
-speciﬁc protein labeling and engineering.
Scheme 7. Cross-metathesis of genetically encoded allyl sulﬁdes or allyl selenides with allyl ethers using a Hoveyda–Grubbs second-generation catalyst for site-speciﬁc
protein labeling and engineering.
Scheme 8. (a) Suzuki–Miyaura cross-coupling reactions between genetically encoded p-iodophenylalanines and aryl- or alkenyl-boronic acids mediated by the water-soluble
palladium catalyst, Pd(OAc)2(ADHP)2. (b) Ligand free Sonogashira cross-coupling reactions between genetically encoded alkyne groups and iodophenyls mediated by the
PdNP generated from Pd(NO3)2.
Scheme 9. Deprotection reactions of a genetically encoded photocaged serine (a) or a photocaged lysine (b) using the photo-uncaging method.
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on E. coli surface. Another famous cross-coupling reaction,
Sonogashira reaction, has also been developed as a bioorthogonal
reaction to label alkyne-encoded proteins. Qing Li and co-workers
ﬁrstly reported a bioorthogonal Pd-mediated Sonogashira cross-
coupling reaction using a robust aminopyrimidine–palladium(II)
complex, which selectively modify a homopropargylglycine
(HPG)-encoded ubiquitin in aqueous medium as well as in
E. coli.37 Recently, Chen and co-workers developed a ligand-free
Pd-mediated Sonogashira cross-coupling reactions system(Scheme 8b), and proved that PdNPs generated from water soluble
Pd(NO3)2 can be an efﬁcient and biocompatible catalyst for site-
speciﬁc labeling of alkyne-modiﬁed proteins inside living E. coli
and other Gram-negative bacterial pathogens such as Shigella.38
Bioorthogonal deprotection reactions
Deprotection reactions through photo-uncaging
The activities of some proteins can be controlled through site-
speciﬁc installations of caging groups on side chains of key
Y. Gong, L. Pan / Tetrahedron Letters 56 (2015) 2123–2132 2129residues that are essential for protein function. Since light irradia-
tion is a relatively noninvasive method, direct caging of proteins
via a genetically encoded unnatural amino acid bearing a
photocleavable group allows photochemically control the func-
tionality or localization of the target proteins in complex cellular
conditions.39 In conventional photocaging strategy, a photocaged
serine or lysine residue bearing a photocleavable group was
designed and genetically encoded into target proteins
(Scheme 9). This photocaged serine or lysine amino acid was
converted to wild type amino acid by irradiation with relatively
low-energy light, and was used to photochemically control the
function of the target protein. In 2011, Chin and co-workers used
this photocaging strategy to control a photocaged MEK1 kinase,
and demonstrated a receptor independent activation of an artiﬁcial
subnetwork within the Raf/MEK/ERK pathway, which provided
new insight into adaptive feedback and the kinetics of single steps
in the MAP kinase signaling cascades.40 More recently, Deiters and
co-workers used this strategy to control a photocaged T7 RNA
polymerase, and demonstrated the photocaging of a synthetic gene
network in mammalian cells.41 The main advantages of this
photocaging strategy are that the unnatural amino acids are site-
speciﬁcally incorporated and the modiﬁed proteins are directly
generated inside the cell, eliminating the requirement for addi-
tional transfection or injection.
Deprotection reactions through palladium-mediated uncaging
Even using non-phototoxic light, the poor penetration ability of
light hinders the further utilizations of these photo-uncagingmeth-
ods in deep tissues or intact animals. To avoid these limitations,
Chen and co-workers recently reported the development of a
palladium-mediated chemical uncaging method to control lysine-
dependent activation of intracellular proteins (Scheme 10).42 In this
method, they ﬁrstly used a genetically encoded lysine analogue
bearing a propargyl carbamate group to protect a key lysine residue
of the target protein, then used biocompatible and efﬁcient
palladium catalysts, such as allyl2Pd2Cl2, to cleave the propargyl
carbamate group of the protected lysine analogue to generate a free
lysine residue. This palladium-mediated deprotection strategy was
further proved to work with a range of different proteins and cell
lines, and was successfully used to reveal the detail virulence
mechanism of a bacterial Type III effector protein.42
Ligand-directed reactions for site-speciﬁc protein labeling and
engineering
Unlike the incorporations of unnatural amino acids by gene
manipulation, which made the target proteins no longer endoge-
nous, the ligand-directed protein labeling method can achieve
the site-speciﬁc labeling of an endogenous target protein.
Recently, a ligand-directed tosyl (LDT) chemistry employing a
unique LDT reagent, which consists of a target protein binding
ligand, a reactive tosyl linker and a functional probe, has been
developed to label natural proteins (Scheme 11a). The tosyl linker
of the LDT reagent behaves not only as a linker between the ligandScheme 10. Deprotection reactions of a genetically encoded caged lysine with thand the probe, but also as a reactive group.5,43 When the LDT
reagent binds to the target protein, a SN2-type reaction is triggered
due to the proximity effect between the tosyl moiety and a nucle-
ophilic amino acid located at the vicinity of the ligand-binding
pocket of target proteins, resulting in the site-speciﬁc labeling of
the target protein and release of the ligand moiety. This labeling
method can be applied for the site-speciﬁc modiﬁcation of a vari-
ety of endogenous proteins under intracellular environments.5,44
The power of LDT chemistry for characterizations of both the target
protein and the ligand-binding sites has been well demonstrated.45
Moreover, combining with ﬂuorescent protein tag technology and
FRET imaging, the LDT chemistry has been demonstrated to con-
struct a natural protein as a ﬂuorescent reporter, which can be
used to detect its molecular interactions in vitro and in living
cells.46
Meanwhile, additional ligand-directed chemoselective reac-
tions based on different reactive linkers have been developed.
Hideaki Kakeya and co-workers reported the use of 5-sulfonyl
tetrazole as the reactive linker to develop a ligand-directed
reaction for site-speciﬁc protein modiﬁcations (Scheme 11b).
They employed this method to achieve the chemical labeling of
the cellular receptor of the natural product, cyclosporine A.47
Using an acyl phenol moiety as the reactive linker, Fenical group
demonstrated another ligand-directed chemoselective reaction
for site-speciﬁc protein modiﬁcations (Scheme 11c), which was
successfully applied to identify the target protein of the anticancer
natural product, marrinopyrrole A.48 Based on a bifunctional O-
NBD unit (NBD: nitrobenzoxadiazole), Sodeoka group reported a
simple ligand-directed chemoselective probe for site-speciﬁc pro-
tein labeling (Scheme 11d). The O-NBD unit is non-ﬂuorescent,
but can be converted into a ﬂuorogenic amino NBD group when
reacted with a Lys residue. After using the O-NBD unit attached
N,N-dialkyl-2-phenylindol-3-ylglyoxylamides (PIGAs), which are
ligands of translocator protein (TSPO), they were able to visualize
the mitochondria expressing TSPO in living cells.49
More recently, a new type of ligand-directed chemistry, known
as ligand-directed acyl imidazole (LDAI) chemistry, has been
developed (Scheme 11e).50 In this LDAI labeling method, a triple
functional LDAI reagent is used, which contains a moderately reac-
tive alkyloxyacyl imidazole linker in addition to a target protein
binding group and a functional probe. Similar to the tosyl linker
in LDT chemistry, the alkyloxyacyl imidazole linker can react with
an accessible nucleophilic residue of target protein assisted by
ligand binding. The power of LDAI chemistry has been proved by
its broad applications to selective chemical labeling of various
types of membrane proteins under living cell conditions for func-
tional studies.51 In addition to introducing the functional probe,
the LDAI chemistry can also be applied to construct caged proteins
in a rational one-step manner, which was demonstrated by Itaru
Hamachi and his co-workers (Scheme 11f). They showed that the
activity of the caged carbonic anhydrase I was almost fully sup-
pressed and absolutely recovered by light irradiation under
in vitro conditions.52 Since LDAI reagents can react with Ser, Tyr,e propargyl group using a palladium-mediated chemical uncaging method.
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Glu residues, therefore these two methods are mutually
complementary.52The application of catalysts has also been introduced in ligand-
directed chemistry. Hamachi group pioneered the development of
catalyst-mediated ligand-directed chemoselective reactions for
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Y. Gong, L. Pan / Tetrahedron Letters 56 (2015) 2123–2132 2131site-speciﬁc protein modiﬁcation using the afﬁnity-guided N,N-
dimethylaminopyridine (AGD) catalysts, which transfer acyl donor
probes to nucleophilic residues near the ligand-binding site of the
target protein through an SN2-type reaction (Scheme 12a).53
Recently, Hiroyuki Nakamura and co-workers developed a
ligand-directed site-speciﬁc protein modiﬁcation method based
on local single-electron transfer (SET) catalysis (Scheme 12b). In
this catalyst-mediated method, a single-electron transfer between
the ruthenium tris(2,20-bipyridyl) complex ([Ru(bpy)3]2+) and a
nearby Tyr residue of the targeted protein generates the tyrosyl
radical that can react with tyrosyl radical trapping agents contain-
ing an N0-acyl-N,N-dimethyl-1,4-phenylenediamine unit through a
catalytic oxidative radical addition reaction.54
Conclusions and perspectives
Recent progress of chemical biology has provided signiﬁcant
advances in the ﬁeld of selective protein modiﬁcations with func-
tional small molecules. Two important strategies based on the
bioorthogonal reactions for site-speciﬁc protein labeling and engi-
neering are summarized in this review. The development of the
bioorthogonal reactions coupled with the genetic-code expansion
method not only revolutionized our abilities to site-speciﬁcally
label and manipulate intact proteins, but also will have important
implications for future practical applications. Meanwhile, with the
development of new reagents, the ligand-directed reactions will
become increasingly powerful for site-speciﬁc labeling andengineering of endogenous proteins. However, it is worthwhile to
point out that the use of organic chemistry for labeling and
manipulating endogenous proteins in their native conditions is
currently still in its infancy and none of these bioorthogonal
reactions mentioned in this review are fully perfect inside living
cells. Thus, future efforts are expected to improve the reaction
biocompatibility and speciﬁcity, and to enhance the reaction
efﬁciency as well as to invent new organic chemistry based tools
that can efﬁciently and site-speciﬁcally label and engineer natural
proteins in living systems.
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